Evidence map›Paper›PMID 25565413›Full record

ReviewNucleus (Austin, Tex.)2015

The ubiquitous transcription factor CTCF promotes lineage-specific epigenomic remodeling and establishment of transcriptional networks driving cell differentiation.

Julie Dubois-Chevalier, Bart Staels, Philippe Lefebvre, Jérôme Eeckhoute

Open access · goldAbstract readReview
In one paragraph

Review in Nucleus (Austin, Tex.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Jund orchestratesProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Julie Dubois-Chevaliera Inserm UMR U1011 ; Lille , France.
Bart Staels
Philippe Lefebvre
Jérôme Eeckhoute
Institut Pasteur de Lille · FREuropean Genomic Institute for Diabetes · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell differentiation relies on tissue-specific transcription factors (TFs) that cooperate to establish unique transcriptomes and phenotypes. However, the role of ubiquitous TFs in these processes remains poorly defined. Recently, we have shown that the CCCTC-binding factor (CTCF) is required for adipocyte differentiation through epigenomic remodelling of adipose tissue-specific enhancers and transcriptional activation of Peroxisome proliferator-activated receptor gamma (PPARG), the main driver of the adipogenic program (PPARG), and its target genes. Here, we discuss how these findings, together with the recent literature, illuminate a functional role for ubiquitous TFs in lineage-determining transcriptional networks.

Indexed as

Chromatin Assembly and DisassemblyGene Regulatory NetworksAnimalsCCCTC-Binding FactorCell DifferentiationCell LineageEpigenomicsHumansRepressor ProteinsCCCTC-Binding FactorCTCF protein, humanRepressor Proteins5hmC, 5-hydroxymethylcytosine5mC, 5-methylcytosineCCCTC-binding factor (CTCF)CEBP, CCAAT/enhancer binding proteincell differentiationcistromeCTCF, CCCTC-binding factorDNA hydroxymethylationenhancerepigenomeH3K27ac, acetylation of histone H3 lysine 27H3K4me1, monomethylation of histone H3 lysine 4KLF, Krüppel-like factorsPPARG, Peroxisome proliferator-activated receptor gammaTET methylcytosine dioxygenaseTET, Ten-eleven translocation methylcytosine dioxygenaseTF, Transcription factortranscriptomeubiquitous transcription factor

Identifiers

PMID25565413
PMCPMC4615151
OpenAlexW1555739057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.